Andrew Gengos - Net Worth and Insider Trading
Andrew Gengos Net Worth
The estimated net worth of Andrew Gengos is at least $52,521 dollars as of 2024-12-27. Andrew Gengos is the CFO and Chief Business Officer of Athira Pharma Inc and owns about 97,532 shares of Athira Pharma Inc (ATHA) stock worth over $52,521. Details can be seen in Andrew Gengos's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Gengos has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Gengos
Andrew Gengos Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Gengos owns 4 companies in total, including Synlogic Inc (SYBX) , EOM Pharmaceutical Holdings Inc (IMUC) , and Cyteir Therapeutics Inc (CYTT) among others .
Click here to see the complete history of Andrew Gengos’s form 4 insider trades.
Insider Ownership Summary of Andrew Gengos
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYBX | Synlogic Inc | 2017-10-09 | See Remarks |
| IMUC | EOM Pharmaceutical Holdings Inc | 2016-12-31 | director |
| CYTT | Cyteir Therapeutics Inc | 2021-06-17 | Chief Business Officer |
 | | 2024-09-05 | See Below |
Andrew Gengos Latest Holdings Summary
Andrew Gengos currently owns a total of 1 stock. Andrew Gengos owns 97,532 shares of Athira Pharma Inc (ATHA) as of September 5, 2024, with a value of $52,521.
Latest Holdings of Andrew Gengos
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2024-09-05 | 97,532 | 0.54 | 52,521 |
Holding Weightings of Andrew Gengos
Andrew Gengos Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Gengos has made a total of 5 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in Athira Pharma Inc is the sale of 1,272 shares on September 5, 2024, which brought Andrew Gengos around $725.
Insider Trading History of Andrew Gengos
- 1
Andrew Gengos Trading Performance
GuruFocus tracks the stock performance after each of Andrew Gengos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Gengos is -32.75%. GuruFocus also compares Andrew Gengos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Gengos within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Gengos's insider trading performs compared to the benchmark.
Performance of Andrew Gengos
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.55 | | | | | |
| Relative Return to S&P 500(%) | -18.12 | | | | | |
Andrew Gengos Ownership Network
Andrew Gengos Owned Company Details
What does Synlogic Inc do?
Who are the key executives at Synlogic Inc?
Andrew Gengos is the See Remarks of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .
Synlogic Inc (SYBX) Insider Trades Summary
Over the past 18 months, Andrew Gengos made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .
In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.
Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synlogic Inc Insider Transactions
Andrew Gengos Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Gengos. You might contact Andrew Gengos via mailing address: 21900 Burbank Boulevard, 3rd Floor, Woodland Hills Ca 91367.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
